Spotlight on the cardiac safety of new traditional Chinese medicines in clinical trials
ZHU Xian-hui
LIU Bing-lin
TANG Jian-yuan
XUE Fei-ran
Abstract:Cardiac safety is one of the emphases which should be focused on in the clinical trials of new traditional Chinese medicines.However,there is little attention paid to this issue currently.Besides,there are some problems in the designing,processing and follow up of clinical trials because of the attitudes of the investigators,various influencing factors of new traditional Chinese medicines,and complicated mechanism and so on.It is important to evaluate the cardiac safety of new traditional Chinese medicines in a scientific,rational and standardized way by integrating the western and Chinese technology and learning from the ancient and modern theories.It is crucial to pay more attention to the early stage and long-term research of clinical trials.Besides,a standardized,rational,complete and practical protocol of clinical trial and an objective,scientific and consistent evaluation of cardiac safety data are very important.
Keywords:new traditional Chinese medicineclinical trialcardiac safety
Publication Date:2017-01-01
Online Publishing Date:2026-08-14(First online date of this platform, not the publication date of the document)
Pages:5( 1498-1502 )
Chinese Journal of New Drugs

Chinese Journal of New Drugs

PKUISTIC
ISSN:1003-3734
Year, Vol.(Issue):2017,26(13)